GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Takeda Pharmaceutical
Takeda, one of Asia's pharmaceutical giants, writes its history through scientific breakthroughs and strategic acquisitions. Its share price is the result of a balance between successful drugs, expiring patents, and the ability to integrate new assets for future growth.
Share prices of companies in the market segment - Pharma holding
Takeda is Japan's largest pharmaceutical company with a global presence, focused on gastroenterology, oncology, and rare diseases. We classify it as a Pharma Holding, and the chart below reflects the overall performance of this segment.
Broad Market Index - GURU.Markets
Takeda is one of the world's leading biopharmaceutical companies, focusing on oncology, gastroenterology, and rare diseases. Its global scale makes it a component of the GURU.Markets index. The chart below shows the US market. See how Takeda shares compare to the overall healthcare trend.
Change in the price of a company, segment, and market as a whole per day
TAK - Daily change in the company's share price Takeda Pharmaceutical
Takeda is a global Japanese pharmaceutical company with a diversified portfolio. Its daily share price fluctuations reflect the inherent volatility of the healthcare sector. This seemingly mundane metric is a crucial component of the analytical formulas on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Pharma holding
Takeda Pharmaceutical Company Limited is Japan's largest pharmaceutical company. This chart shows the average daily volatility of the global pharmaceutical industry. Comparison with TAK's dynamics helps assess how its focus on rare diseases and the gastrointestinal tract impacts its risk profile compared to other major pharmaceutical companies.
Daily change in the price of a broad market stock, index - GURU.Markets
Takeda is Japan's largest pharmaceutical company with a global presence. The pharmaceutical sector may operate by its own rules, but shares of such giants are still subject to overall market trends. The chart below shows overall market dynamics, allowing you to assess how Takeda fits into the global landscape.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Takeda Pharmaceutical
Takeda, Japan's largest pharmaceutical company, has seen growth in its portfolio of drugs for rare diseases and gastrointestinal tract disorders over the past year. The year-over-year share price performance, shown in the chart, reflects the market's assessment of its global strategy and R&D success.
Annual dynamics of market capitalization of the market segment - Pharma holding
Takeda Pharmaceutical Company Limited is Japan's largest pharmaceutical company with a global presence. Following the acquisition of Shire, it became a leader in rare diseases. The chart below shows how this strategic transformation and focus on specialty drugs are impacting its positioning within global Big Pharma.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Takeda Pharmaceutical is Japan's largest pharmaceutical company with a global presence. Its growth is driven by success in drug development, particularly in gastroenterology and rare diseases. A comparison with the market will reveal how investors view its international portfolio and research capabilities.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Takeda Pharmaceutical
Takeda Pharmaceutical's (TAK) medium-term market capitalization (Perf_Month_Co) is sensitive to key milestones in the pharmaceutical business: clinical trial results, regulatory approvals of new drugs, and the success of its blockbuster portfolio. Each significant news cycle or patent risk can trigger significant monthly fluctuations, reflecting the high cost of R&D and its dependence on pipeline products.
Monthly dynamics of market capitalization of the market segment - Pharma holding
This chart shows the dynamics of the entire pharmaceutical sector. For Takeda, Japan's largest pharmaceutical company, it serves as a backdrop. It illustrates how the company, managing a diversified drug portfolio, competes in the global market.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Takeda is a global pharmaceutical giant whose business is based on the development and sale of life-saving drugs. The chart below shows the overall market sentiment, which is subject to economic cycles. This allows us to assess whether Takeda acted as a defensive asset during periods of market instability or whether news about its own drugs forced it to pursue its own course.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Takeda Pharmaceutical
Shares of Takeda Pharmaceutical, Japan's largest pharmaceutical company, reflect global healthcare trends on a weekly basis. Price movements reflect clinical trial results, strategic deals, and advances in drug development for rare diseases and oncology.
Weekly dynamics of market capitalization of the market segment - Pharma holding
Large pharmaceutical holdings are a sector whose weekly performance is driven by news about clinical trials, patent expirations, and mergers. These events set the tone for the entire industry. This chart illustrates this general backdrop, which can be used to evaluate Takeda's strategy and drug portfolio.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Takeda is a major Japanese pharmaceutical company with a global presence. Like other big pharma giants, its business is diversified, which can ensure stability. The chart shows how Takeda shares are a "defensive" asset, weakly affected by market fluctuations due to the constant demand for its drugs.
Market capitalization of the company, segment and market as a whole
TAK - Market capitalization of the company Takeda Pharmaceutical
Takeda's market capitalization tells the story of the century-old Japanese company's transformation into a global biopharmaceutical leader, particularly following the acquisition of Shire. The chart reflects both the enormous potential of its drug portfolio and the challenges associated with integration and debt. Its dynamics reflect the market's assessment of this ambitious and risky strategy.
TAK - Share of the company's market capitalization Takeda Pharmaceutical within the market segment - Pharma holding
Takeda is Japan's largest pharmaceutical company and a global leader. Its significant market share was achieved through the acquisition of Shire, making it a strong player in rare diseases. The chart demonstrates the weight of this global giant, combining Japanese traditions with international reach.
Market capitalization of the market segment - Pharma holding
Takeda Pharmaceutical is Japan's largest pharmaceutical company with a global presence. The chart below shows the overall market capitalization of this research- and capital-intensive sector. Its dynamics reflect both general trends in healthcare and the successes and failures of new blockbuster drug development.
Market capitalization of all companies included in a broad market index - GURU.Markets
Takeda Pharmaceutical is Japan's largest pharmaceutical company with global reach. Its market capitalization is the result of a combination of research and strategic acquisitions. Its weight on the overall chart reflects how Asian pharmaceutical giants are becoming key players in the global healthcare market.
Book value capitalization of the company, segment and market as a whole
TAK - Book value capitalization of the company Takeda Pharmaceutical
The balance sheet of Japanese pharmaceutical giant Takeda is comprised of its global network of research centers, manufacturing facilities, and patent portfolio, strengthened by the acquisition of Shire. This represents real, international capital focused on tackling complex diseases. How has this foundation changed since the mega-merger? The chart below tells the story.
TAK - Share of the company's book capitalization Takeda Pharmaceutical within the market segment - Pharma holding
Takeda, as a global pharmaceutical company, has an extensive network of research laboratories and manufacturing facilities. The chart shows the share of these knowledge-intensive tangible assets in the sector, reflecting the physical scale behind drug development and production.
Market segment balance sheet capitalization - Pharma holding
Global pharmaceuticals on Takeda's scale are both knowledge- and capital-intensive. Owning major R&D centers and manufacturing facilities around the world makes it a heavyweight among the assets of the entire healthcare sector.
Book value of all companies included in the broad market index - GURU.Markets
Takeda's book value reflects a global network of advanced research centers and pharmaceutical manufacturing facilities, inherited and built by one of the world's oldest pharmaceutical companies. Its assets reflect its manufacturing and research capabilities in drug development. The chart illustrates the physical scale of this Japanese giant in the global pharmaceutical industry.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Takeda Pharmaceutical
Takeda, the Japanese pharmaceutical giant, is valued near its book value. This may reflect investor concerns about its debt burden following major mergers and generic competition, despite its strong drug pipeline.
Market to book capitalization ratio in a market segment - Pharma holding
Takeda is a large Japanese pharmaceutical company with a global presence. Its value is determined by its existing drug portfolio and the potential for new developments. The chart shows how the market values its scientific potential and its ability to offset patent expirations on older drugs.
Market to book capitalization ratio for the market as a whole
Takeda Pharmaceutical is Japan's largest pharmaceutical company with a global presence. Its value is determined by its portfolio of patented drugs and promising developments. This metric reflects how investors assess the company's ability to bring new blockbuster drugs to market, a key driver of value creation in the pharmaceutical industry.
Debts of the company, segment and market as a whole
TAK - Company debts Takeda Pharmaceutical
Takeda Pharmaceutical, a major Japanese pharmaceutical company, significantly increased its debt burden after acquiring Shire. Its current financial strategy is aimed at gradually reducing debt using cash flows from the combined drug portfolio. This chart clearly illustrates the impact of this transformative M&A deal.
Market segment debts - Pharma holding
Takeda is a Japanese pharmaceutical company with a global presence that grew significantly after acquiring Shire. Such large deals are typically financed with significant debt. This chart clearly demonstrates Takeda's debt load after this transformational transaction and its subsequent strategy to reduce its debt burden and integrate new businesses.
Market debt in general
Takeda is a large Japanese pharmaceutical company with a global presence. Its acquisition of Shire, financed with significant debt, provided a significant boost to its growth. This chart helps assess how Takeda is managing this debt burden and the sustainability of its financial strategy in the context of a stable but competitive pharmaceutical market.
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Takeda Pharmaceutical
Takeda, a major global pharmaceutical company, significantly increased its debt after acquiring Shire. This chart clearly illustrates the financial impact of this deal. For investors, it is a key indicator of how successfully the company is paying down its debt through synergies and sales growth of new drugs.
Market segment debt to market segment book capitalization - Pharma holding
Takeda Pharmaceutical, Japan's largest pharmaceutical company with a global presence and a growing focus on acquisitions, charts its debt relative to the overall market capitalization of the pharmaceutical sector. It clearly demonstrates how strategic acquisitions like Shire have impacted the company's debt load and financial profile.
Debt to book value of all companies in the market
Takeda, a major pharmaceutical company, enjoys stable demand for its products. This chart compares its significant debt, acquired through acquisitions, to the overall market capitalization. It helps understand how the company manages its large balance sheet against the backdrop of general economic cycles, highlighting the defensive nature of its business.
P/E of the company, segment and market as a whole
P/E - Takeda Pharmaceutical
Takeda Pharmaceutical is Japan's largest pharmaceutical company with a global presence, specializing in rare diseases, oncology, and gastroenterology. This chart shows how investors value its drug portfolio following its major acquisition of Shire. The valuation depends on successful integration and the launch of new drugs.
P/E of the market segment - Pharma holding
Takeda Pharmaceutical is Japan's largest pharmaceutical company and a global leader, specializing in oncology, rare diseases, and gastroenterology. This chart shows the average valuation for large pharmaceutical holdings, allowing investors to compare Takeda's global portfolio and scientific potential with its peers.
P/E of the market as a whole
Takeda is a Japanese pharmaceutical company with a global presence, specializing in rare diseases and gastroenterology. The valuation of large pharmaceutical companies depends on the success of their drugs and the expiration of patents. To what extent is Takeda susceptible to general market sentiment, and to what extent does it operate within its own cycle of scientific development and commercialization?
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Takeda Pharmaceutical
Takeda Pharmaceutical is Japan's largest pharmaceutical company with a global presence, specializing in rare diseases and gastroenterology. This chart reflects analyst expectations for the commercial success of its key drugs and the results of clinical trials of new drugs.
%20P%2FE%20Takeda%20Pharmaceutical&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Takeda-Pharmaceutical&v=1772513748676 "Chart of the company's future (projected) P/E Takeda Pharmaceutical")
Future (projected) P/E of the market segment - Pharma holding
Takeda Pharmaceutical is Japan's largest pharmaceutical company with a global presence, specializing in gastroenterology, oncology, and rare diseases. This chart shows analysts' forecasts for Takeda's future profitability. It reflects the market's assessment of its drug portfolio and its ability to integrate major acquisitions, such as Shire.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20holding&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-holding&v=1772513748678 "Future (projected) P/E graph of the market segment - Pharma holding")
Future (projected) P/E of the market as a whole
Takeda is a major Japanese pharmaceutical company with a global presence, specializing in rare diseases and oncology. This graph of overall market expectations highlights the defensive nature of their business. Demand for life-saving drugs remains stable regardless of economic ups and downs.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513748682 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Takeda Pharmaceutical
Takeda Pharmaceutical is Japan's largest pharmaceutical company with a global presence, specializing in rare diseases and gastroenterology. This chart shows the financial results of its strategy, which focuses on niche, high-margin drugs. Profitability depends on the success of key drugs and the integration of past acquisitions.
Profit of companies in the market segment - Pharma holding
Takeda Pharmaceutical is Japan's largest pharmaceutical company with a global presence, specializing in gastroenterology, oncology, and rare diseases. This chart shows the profitability dynamics of its pharmaceutical holdings. Takeda's strategy, focused on innovation and acquisitions, allows it to compete globally and influence the entire industry.
Overall market profit
Takeda Pharmaceutical is a global biopharmaceutical company focused on oncology, rare diseases, and gastroenterology. Demand for its key drugs is driven by patient needs, not economic cycles. However, the overall state of the economy, which can be assessed from this chart, impacts healthcare systems and their ability to fund innovative treatments.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Takeda Pharmaceutical
Takeda Pharmaceutical is Japan's largest pharmaceutical company with a global presence. This chart shows analysts' expectations for future earnings, which hinge on sales of key drugs for rare diseases and oncology, as well as the successful integration of the acquired Shire company and the development of new drugs.
%20profit%20of%20the%20company%20Takeda%20Pharmaceutical&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Takeda-Pharmaceutical&v=1772513748748 "Graph of future (projected) profit of the company Takeda Pharmaceutical")
Future (predicted) profit of companies in the market segment - Pharma holding
Takeda Pharmaceutical is Japan's largest pharmaceutical company with a global presence, specializing in rare diseases and gastroenterology. The industry-wide profit forecasts shown in the chart reflect broad trends and serve as a backdrop for assessing the success of Takeda's drug portfolio and R&D efforts.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20holding&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-holding&v=1772513748760 "Graph of future (predicted) profits of companies in a market segment - Pharma holding")
Future (predicted) profit of the market as a whole
Takeda Pharmaceutical is a major Japanese pharmaceutical company with a global presence. Demand for its drugs, particularly in areas such as oncology and rare diseases, is less susceptible to economic cycles. However, the overall health of the economy, reflected in the chart, impacts healthcare systems and the availability of funding for innovation.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513748766 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Takeda Pharmaceutical
Takeda is Japan's largest pharmaceutical company with a global presence. Its revenue is diversified across several therapeutic areas. This chart shows how the market views its sales. Investors analyze it to understand how successfully the company integrates acquired assets and brings new drugs to market.
P/S market segment - Pharma holding
Takeda Pharmaceutical is Japan's largest pharmaceutical company with a global presence, specializing in drugs for the treatment of oncology, rare diseases, and gastrointestinal diseases. Revenue depends on the success of its drug portfolio. This chart shows the average valuation in the sector, which helps understand how the market views Takeda's diversification and scientific potential.
P/S of the market as a whole
Takeda Pharmaceutical is Japan's largest pharmaceutical company with a global presence. It specializes in developing drugs in areas such as oncology, gastroenterology, and rare diseases. This chart shows how the market values the global pharmaceutical giant's revenue compared to the overall revenue estimates for all companies.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Takeda Pharmaceutical
Takeda is a large Japanese pharmaceutical company with a global presence, particularly strong in gastroenterology and oncology. This chart shows how investors estimate its future drug revenue. This estimate depends on the success of its key drugs and its ability to expand its portfolio with new developments.
%20P%2FS%20Takeda%20Pharmaceutical&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Takeda-Pharmaceutical&v=1772513748867 "The graph of the company's future (projected) P/S Takeda Pharmaceutical")
Future (projected) P/S of the market segment - Pharma holding
Takeda Pharmaceutical is Japan's largest pharmaceutical company with a global presence, specializing in rare diseases, oncology, and gastroenterology. This chart compares the company's estimated future sales with those of other pharmaceutical holdings. It shows how investors view its drug portfolio and its ability to bring new, successful drugs to market.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20holding&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-holding&v=1772513748907 "Future (projected) P/S market segment graph - Pharma holding")
Future (projected) P/S of the market as a whole
Takeda is a large Japanese pharmaceutical company with a global presence, focused on innovative drugs. Its success depends on research and development, not short-term economic cycles. This chart provides a general overview, but Takeda's true growth drivers are successful clinical trials and the launch of new drugs.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513748922 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Takeda Pharmaceutical
This is the revenue chart for Takeda Pharmaceutical, one of Asia's largest pharmaceutical companies. Revenue is generated from sales of a broad portfolio of drugs in areas such as gastroenterology, oncology, and rare diseases. Revenue growth reflects the successful launch of new drugs, patent expirations on older drugs, and strategic acquisitions such as the purchase of Shire.
Sales of companies in the market segment - Pharma holding
Takeda is Japan's largest pharmaceutical company with a global presence. It specializes in drugs for the treatment of oncology, rare diseases, and gastrointestinal diseases. This chart shows the total revenue of its pharmaceutical holdings. It reflects global healthcare spending and demand for the innovative drugs Takeda develops and commercializes.
Overall market sales
Takeda Pharmaceutical is a global pharmaceutical company focused on oncology, rare diseases, and gastroenterology. Demand for its specialized drugs is largely unaffected by short-term economic fluctuations. However, long-term economic growth, as illustrated by this chart, ensures the stability of healthcare systems and their ability to fund innovative treatments.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Takeda Pharmaceutical
Takeda Pharmaceutical is Japan's largest pharmaceutical company with a global presence, focused on gastroenterology, oncology, and rare diseases. This revenue forecast chart reflects sales expectations for its key products. The growth is driven by forecasts of increased demand for its drug portfolio and the successful launch of new products.
%20sales%20of%20the%20company%20Takeda%20Pharmaceutical&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Takeda-Pharmaceutical&v=1772513749044 "Schedule of future (projected) sales of the company Takeda Pharmaceutical")
Future (projected) sales of companies in the market segment - Pharma holding
Takeda is Japan's largest pharmaceutical company with a global presence. It specializes in the development and production of drugs in areas such as oncology, gastroenterology, and rare diseases. This chart shows projected revenues for the entire pharmaceutical holding sector, reflecting overall trends in healthcare spending and drug development.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20holding&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-holding&v=1772513749053 "Schedule of future (projected) sales of companies in the market segment - Pharma holding")
Future (projected) sales of the market as a whole
Takeda is a global pharmaceutical company focused on innovative drugs. While demand for many of its drugs is inelastic, the overall economic situation impacts healthcare systems. Stable economic growth, predicted by positive sales forecasts, ensures sustainable financing and patient access to advanced treatments.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513749058 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Takeda Pharmaceutical
Takeda is a large Japanese pharmaceutical company with a global presence, specializing in oncology, rare diseases, and gastroenterology. This chart shows its ability to generate profits after major acquisitions, such as Shire. This performance depends on successful integration and sales growth of key proprietary drugs.
Market segment marginality - Pharma holding
Takeda Pharmaceutical is Japan's largest pharmaceutical company with a global presence. Its success depends on the profitability of its drug portfolio, particularly in areas such as gastroenterology, oncology, and rare diseases. This chart shows the average profitability in the pharmaceutical industry. It helps assess the success of Takeda's strategy following major acquisitions.
Market marginality as a whole
Takeda Pharmaceutical is a large Japanese pharmaceutical company with a global presence, specializing in rare diseases and gastroenterology. Demand for its key drugs is inelastic and weakly correlates with overall profitability, as shown in the graph. The company's success is determined by research results, patent validity, and the effectiveness of commercializing new drugs.
Employees in the company, segment and market as a whole
Number of employees in the company Takeda Pharmaceutical
Takeda is Japan's largest pharmaceutical company with a global presence. Following its massive acquisition of Shire, the company manages a vast portfolio of drugs. This chart shows the size of its international team of scientists, clinicians, and marketers working to develop and promote innovative treatments.
Share of the company's employees Takeda Pharmaceutical within the market segment - Pharma holding
Takeda Pharmaceutical is a global, science-driven pharmaceutical company. Developing and commercializing drugs worldwide requires a massive global workforce of scientists, clinicians, and sales professionals. This chart reflects its position as a global pharmaceutical leader, demonstrating the significant portion of the industry's workforce it employs for its operations.
Number of employees in the market segment - Pharma holding
Takeda is Japan's largest pharmaceutical company with a global presence, specializing in rare diseases and gastroenterology. This chart illustrates the scale of the transnational pharmaceutical industry. Employment dynamics reflect both advances in new drug development and complex integration processes following major acquisitions, such as the purchase of Shire.
Number of employees in the market as a whole
Takeda Pharmaceutical is a Japanese pharmaceutical giant with a vast global presence. The company's hiring trends, particularly in areas such as oncology and rare diseases, point to the future of pharmaceutical innovation and where new jobs will be created.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Takeda Pharmaceutical (TAK)
Takeda is a major global pharmaceutical company. Its value lies in its portfolio of patented drugs and extensive R&D program. This graph reflects the research-intensive nature of its business. The company's high value stems not only from its large workforce but also from its intellectual property, which can generate billions of dollars in revenue.
%20of%20the%20company%20Takeda%20Pharmaceutical%20(TAK)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Takeda-Pharmaceutical-TAK&v=1772513749149 "Chart of market capitalization per employee (in thousands of dollars) of the company Takeda Pharmaceutical (TAK)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma holding
Takeda is Japan's largest pharmaceutical company with a global presence. Like other "big pharma" companies, its value lies in its R&D and patented drug portfolio. This metric, compared to the industry average, reflects how highly the market values a company's scientific potential and existing blockbusters per employee.
%20by%20market%20segment%20-%20Pharma%20holding&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-holding&v=1772513749151 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma holding")
Market capitalization per employee (in thousands of dollars) for the overall market
Takeda Pharmaceutical is a global biopharmaceutical company focused on research. This chart reflects the value of intellectual property in the pharmaceutical industry. The company's patented drug portfolio, developed by a team of scientists, generates billions in revenue. High margins and innovation generate a huge market value per employee.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513749155 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Takeda Pharmaceutical (TAK)
Takeda Pharmaceutical is Japan's largest pharmaceutical company with a global presence, strong in oncology and rare diseases. Pharmaceuticals are all about R&D and high margins. This chart shows how productive their R&D investments are. Their high profit per employee is a direct result of sales of expensive, patented drugs.
%20Chart%20Takeda%20Pharmaceutical%20(TAK)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Takeda-Pharmaceutical-TAK&v=1772513749156 "Company Profit Per Employee (in thousands of dollars) Chart Takeda Pharmaceutical (TAK)")
Profit per employee (in thousands of dollars) in the market segment - Pharma holding
Takeda is Japan's largest pharmaceutical giant. This chart sets the benchmark for "Pharma Holdings." The average profit per employee in this sector is astronomical. It's a "blockbuster business." A single successful drug patent can generate billions, more than recouping R&D costs and ensuring high profits per scientist.
%20in%20the%20market%20segment%20-%20Pharma%20holding&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-holding&v=1772513749158 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma holding")
Profit per employee (in thousands of dollars) for the market as a whole
Takeda is a Japanese pharmaceutical company with a global presence. Its success is based on scientific research and drug development, which requires years of dedicated research by its scientists. This chart illustrates how the research-intensive pharmaceutical industry can generate high profits by monetizing its intellectual property.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513749163 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Takeda Pharmaceutical (TAK)
Takeda is a large Japanese pharmaceutical company with a global presence, especially after its acquisition of Shire. This chart shows how effectively the company monetizes its drug portfolio. The high revenue per employee reflects successful sales of key drugs and the company's ability to integrate acquired assets.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Takeda-Pharmaceutical-TAK&v=1772513749175 "Sales chart per company employee Takeda Pharmaceutical (TAK)")
Sales per employee in the market segment - Pharma holding
Takeda is Japan's largest pharmaceutical company with a global presence (especially after the acquisition of Shire). They focus on complex drugs (oncology, gastrointestinal tract, rare diseases). It's an R&D-intensive business. This chart shows the industry average per employee income. It helps assess the productivity of Takeda's R&D and commercial teams.
Sales per employee for the market as a whole
Takeda Pharmaceutical is Japan's largest pharmaceutical company with global reach, with a strong presence in gastroenterology and rare disease treatment. Their business focuses on R&D and global drug sales. This metric reflects how well their patented drug portfolio, developed by their team of scientists, generates revenue worldwide.
Short shares by company, segment and market as a whole
Shares shorted by company Takeda Pharmaceutical (TAK)
Takeda is a large Japanese pharmaceutical company with a global presence, strengthened by the acquisition of Shire. This chart measures bearish sentiment. Bears may be concerned about the high debt left over from the merger or the risk of patent expiration on key drugs, paving the way for cheaper generics.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Takeda-Pharmaceutical-TAK&v=1772513749197 "Short Shares Chart for the Company Takeda Pharmaceutical (TAK)")
Shares shorted by market segment - Pharma holding
Takeda Pharmaceutical is Japan's largest pharmaceutical company with a global presence, focused on oncology, gastroenterology, and rare diseases (after the acquisition of Shire). This chart shows short bets. Shorts on Takeda are often linked to the company's massive debt incurred after the Shire acquisition. Investors may question the company's ability to service its debt while simultaneously expanding its pipeline with new drugs.
Shares shorted by the overall market
Takeda is a global pharmaceutical holding company whose business is based on treating complex diseases. This indicator measures overall investor fear, but demand for Takeda's drugs is not affected by it. Healthcare is not subject to economic cycles. Therefore, during periods of pessimism, as reflected by this chart, the healthcare sector often becomes a safe haven for capital seeking stability.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Takeda Pharmaceutical (TAK)
Takeda, a major Japanese pharmaceutical company, has a diversified portfolio. This oscillator reading above 70 may reflect the success of new drugs or stable earnings. Oversold territory (<30) is often associated with concerns about patent expirations, R&D setbacks, or the impact of exchange rates on earnings.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Takeda-Pharmaceutical-TAK&v=1772513749215 "RSI 14 indicator chart for the company's stock Takeda Pharmaceutical (TAK)")
RSI 14 Market Segment - Pharma holding
Takeda (TAK) is Japan's largest pharmaceutical company with global reach, strong in gastroenterology and rare diseases. This metric measures the "temperature" of the entire pharmaceutical sector. It helps understand: is TAK oversold due to its patent risks or is there a general cooling off toward all of Big Pharma worldwide?
RSI 14 for the overall market
Takeda, a pillar of the Japanese and global pharmaceutical industry, focuses on complex diseases. Pharmaceuticals are often considered a "defensive" sector, where investors retreat during times of uncertainty. But is that really the case? This chart measures the overall level of panic or euphoria in the market. It helps understand whether people are buying TAK shares for its strong drugs or simply seeking a safe haven during a storm.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast TAK (Takeda Pharmaceutical)
Takeda is a leading global pharmaceutical company focused on oncology, rare diseases, and gastroenterology. The company's success depends on the launch of new drugs. This chart summarizes analyst opinions: it shows the average 12-month price forecast based on their current pipeline and clinical trial prospects.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-TAK-Takeda-Pharmaceutical&v=1772513749244 "A chart showing analyst consensus forecasts for the expected stock price. TAK (Takeda Pharmaceutical)")
The difference between the consensus estimate and the actual stock price TAK (Takeda Pharmaceutical)
Takeda (TAK) is one of Japan's oldest and largest pharmaceutical companies, with a global focus on oncology, gastroenterology, and rare diseases. This chart shows analyst opinions on their R&D. It measures the gap between the current price and the consensus estimate, reflecting whether experts believe their pipeline will offset the loss of patents.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-TAK-Takeda-Pharmaceutical&v=1772513749249 "A chart showing the difference between the consensus forecast and the actual stock price. TAK (Takeda Pharmaceutical)")
Analyst consensus forecast for stock prices by market segment - Pharma holding
Takeda is Japan's largest pharmaceutical company, focused on complex treatments in oncology and gastroenterology. Its success depends on R&D, but also on the overall sentiment within "big pharma." This chart reflects the collective opinion of analysts on the entire pharmaceutical segment. It shows whether experts believe in new growth drivers for the industry or expect stagnation.
Analysts' consensus forecast for the overall market share price
Takeda Pharmaceutical is a global pharmaceutical giant focused on oncology and rare diseases. The company's business is often considered defensive, as demand for its drugs is relatively unaffected by economic cycles. This chart shows the general expectations of experts across the market. It helps understand how investors balance risks: whether they seek the safe haven of healthcare if overall sentiment deteriorates, or prefer riskier assets.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Takeda Pharmaceutical
Takeda is one of Asia's leading pharmaceutical companies with global reach, with strengths in oncology, gastroenterology, and rare diseases. The company has focused on innovation and major M&A (such as the acquisition of Shire). This chart provides a comprehensive assessment of their complex strategy: it weighs integration risks, the pressure of patent cliffs, and market confidence in their R&D pipeline.
AKIMA Market Segment Index - Pharma holding
Takeda is a 240-year-old Japanese pharmaceutical giant focused on gastroenterology, rare diseases, and oncology. This composite index measures companies across a variety of factors. The chart shows the industry average. It serves as a barometer: to what extent do Takeda's global strategy and R&D pipeline allow it to outperform the average pharma company?
The AKIM Index for the overall market
Takeda Pharmaceutical is a Japanese global pharmaceutical giant focused on R&D in oncology, gastroenterology, and rare diseases. This sector often operates by its own rules (patents, R&D). This chart, reflecting the market average, provides a backdrop. It helps assess how Takeda, pursuing its scientific goals, compares to the overall macroeconomic picture, which influences investor sentiment.
